In conclusion, activation of the insulin pathway upregulates EZH2 expression in intestinal mucosal T cells during inflammation, which in turn promoted TRM differentiation and disrupted subgroups of IELs and inflammatory cytokines, ultimately exacerbated colitis. The gene discussed is INS; the disease is colitis.